Volume matters: Breast induration is associated with irradiated breast volume in the Danish Breast Cancer Group phase III randomized Partial Breast Irradiation trial.

Assurance Dose volume relationship Partial breast irradiation Quality Randomised trial

Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
12 2022
Historique:
received: 28 07 2022
revised: 22 09 2022
accepted: 29 09 2022
pubmed: 21 10 2022
medline: 21 12 2022
entrez: 20 10 2022
Statut: ppublish

Résumé

The relation between breast induration grade 2-3 at 3 years after radiation therapy and irradiated breast volume was investigated for patients in the Danish Breast Cancer Group (DBCG) Partial Breast Irradiation (PBI) trial. METHODS Treatment plan data was obtained from the Danish radiotherapy plan database. Dosimetric parameters for breast and organs at risk were determined. Breast induration data was obtained from the DBCG database. The volume of the whole breast (CTVp_breast) treated to various dose levels was determined for treatment plans in both arms. Logistic regression was used to assess the frequency of induration on breast volume irradiated to ≥40 Gy. RESULTS PBI and WBI was given to 433 and 432 patients, respectively. Median and interquartile ranges (IQR) for CTVp_breast were 710 mL (467-963 mL; PBI) and 666 mL (443-1012 mL; WBI) (p = 0.98). Median and IQR for CTVp_breast treated to ≥40 Gy was 24.9% (18.6-32.6%; PBI) and 59.8% (53.6-68.5%; WBI). Grade 2-3 induration was observed in 5% (PBI) and 10% (WBI) of the patients. A dose-response relationship was established between irradiated breast volume and frequency of breast induration. From the model, 5% and 10% risks of breast induration were observed for ≥40 Gy delivered to CTVp_breast volumes of 177 mL (95%CI, 94-260 mL) and 426 mL (95%CI, 286-567 mL), respectively. CONCLUSION The frequency of breast induration increased significantly with increasing irradiated breast volume, strongly favouring small volumes and PBI. Thus, treated breast volume - not the breast size itself - is the risk factor for induration. This is the first report directly linking the 40 Gy irradiated breast volume to breast induration.

Identifiants

pubmed: 36265685
pii: S0167-8140(22)04494-2
doi: 10.1016/j.radonc.2022.09.024
pii:
doi:

Types de publication

Clinical Trial, Phase III Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-235

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Mette S Thomsen (MS)

Department of Medical Physics, Aarhus University Hospital, Aarhus, Denmark. Electronic address: mettthom@rm.dk.

Jan Alsner (J)

Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

Hanne M Nielsen (HM)

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

Erik H Jakobsen (EH)

Department of Oncology, Lillebaelt Hospital, Vejle, Denmark.

Mette H Nielsen (MH)

Department of Oncology, Odense University Hospital, Odense, Denmark.

Mette Møller (M)

Department of Oncology, Aalborg University Hospital, Aalborg, Denmark.

Anders N Pedersen (AN)

Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Esben Yates (E)

Department of Medical Physics, Aarhus University Hospital, Aarhus, Denmark.

Martin Berg (M)

Department of Medical Physics, Lillebaelt Hospital, Vejle, Denmark.

Ebbe Lorenzen (E)

Laboratory of Radiation Physics, Odense University Hospital, Odense, Denmark.

Ingelise Jensen (I)

Department of Medical Physics, Aalborg University Hospital, Aalborg, Denmark.

Mirjana Josipovic (M)

Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Jens Overgaard (J)

Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

Birgitte V Offersen (BV)

Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH